Answers from the Lab
298 episodes - English - Latest episode: 3 days ago -A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Alzheimer’s Disease and Testing Innovations: Bill Morice, M.D., Ph.D.
April 25, 2024 06:00 - 11 minutes - 15.5 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss testing innovations for Alzheimer’s disease and cognitive impairments, and how laboratorians can responsibly help shape the future of healthcare. Their discussion includes: The latest news about the U.S. Food and Drug Administration’s (FDA) proposed ...
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D
April 23, 2024 06:00 - 5 minutes - 8.08 MBMaryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and about one-third of patients respond to the new medication. (00:32) Could you provide us with a little bit of information about yourself and your background? (01:18) Can you start with a brief overview of the assay? (02:13) Which pat...
Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.
April 18, 2024 06:00 - 11 minutes - 15.3 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss current events including Medical Laboratory Professionals Week, recent healthcare conferences, advocacy efforts, measles, and bird flu. Their discussion includes: Key takeaways from the Becker’s Healthcare Annual Meeting and the College of American P...
Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D.
April 16, 2024 06:00 - 9 minutes - 12.5 MBMaria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's disease. (00:32) Do you mind giving the audience more information about yourself and your background? (01:53) Could you please give a brief overview of this assay? (03:35) Which patients should have this testing and when should it be pe...
Tick Season Outlook: Elitza Theel, Ph.D.
April 11, 2024 06:00 - 17 minutes - 24.7 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to discuss tick-borne diseases and the latest testing options. Specific topics of discussion include: The types of tick-borne diseases found throughout the United States. Algorithmic approaches and testing methods used to diagnose tick-borne disea...
Noninvasive plasma biomarker testing provides faster answers: Alicia Algeciras-Schimnich, Ph.D.
April 09, 2024 06:00 - 17 minutes - 24.7 MBAlicia Algeciras-Schimnich, Ph.D., discusses how Mayo Clinic Laboratories’ new noninvasive blood test for Alzheimer’s disease identifies the p-tau217 biomarker, which is associated with the accumulation of amyloid beta in the brain. Positive test results can facilitate access to disease-modifying therapies. (00:32): Dr. Algeciras, could you just provide a little bit of background on your role at Mayo Clinic? (01:45): So before we get into the test itself, can you just explain a...
Dengue Outbreaks and Advancements in Colon Cancer Screening: Bill Morice, M.D., Ph.D.
April 04, 2024 18:00 - 11 minutes - 15.3 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss current events including dengue outbreaks, new colon cancer screening technology, and insurance coverage of innovative lab tests. Their discussion includes: The surge of dengue cases in Latin America, and best practices for tick and mosquito bite pre...
Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.
April 02, 2024 06:00 - 8 minutes - 11.6 MBBobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing. (00:33) Do you mind giving us a brief introduction of yourself and what you do at Mayo? (01:45) Can you tell us a little about the test and how it came to be? (03:00) Could you explain the types of patients this test would be best suited...
Why Measles Is on the Rise: Matthew Binnicker, Ph.D.
March 28, 2024 06:00 - 15 minutes - 21.9 MBThe Centers for Disease Control and Prevention (CDC) issued a recent health advisory in response to the increasing number of measles outbreaks in the United States. In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of laboratory medicine and pathology and clinical virologist at Mayo Clinic, to discuss why measles is in the news again and how we can preven...
Targeted panel boosts accuracy of hereditary pancreatitis testing: Experts: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.
March 26, 2024 06:00 - 10 minutes - 14.4 MBLinda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C., explain how Mayo Clinic Laboratories' targeted test panel facilitates accurate diagnosis of hereditary pancreatitis, which heightens the risk for pancreatic cancer. Test results can guide cancer monitoring for patients and their families. (00:33) Dr. Hasadsri, can you tell the audience a little bit about yourself and your background? (01:32) And Ms. Cabral? (02:03) Can you please give the audience a brief ov...
Industry Updates From the Nation’s Capital: Bill Morice, M.D., Ph.D.
March 21, 2024 06:00 - 13 minutes - 18 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss important industry updates and legislative insights gathered from Dr. Morice’s recent trip to Washington, D.C. Their discussion includes: The status of current laboratory-related legislative efforts, including the Protecting Access to Medicare Act (P...
Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC
March 19, 2024 06:00 - 18 minutes - 25.6 MBWei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide cancer surveillance for patients and their families. (00:32) Would each of you share a little bit about yourselves and your background? Dr. Shen? (01:25) Rihanna, could we have you give a little background about yourself as well? (01:48) Could you provide us with an ...
Syphilis Testing Updates: Elitza Theel, Ph.D.
March 14, 2024 06:00 - 19 minutes - 26.3 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to follow up on the syphilis epidemic and discuss updated testing recommendations. Specific topics of discussion include: Background information on syphilis and the epidemic occurring in the United States. The report recently published by the Cente...
Testing aids nicotine-use cessation: Paul Jannetto, Ph.D.
March 12, 2024 06:00 - 9 minutes - 13.5 MBPaul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients in substance-use cessation programs and other settings. The serum and urine tests quantify nicotine and various metabolites. (00:32) Can you tell us a little bit about yourself and your background? (01:42) Can you please provide an overview of substance use disorders, specifically nicotine dependence, and Mayo Clinic's nicotine testing options? (04:33) Which patients should ha...
Final Rule on LDTs May Be Coming Soon: Bill Morice, M.D., Ph.D.
March 07, 2024 07:00 - 10 minutes - 14.7 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the Food and Drug Administration’s (FDA) progress on making a final rule around regulating laboratory-developed tests (LDTs). Their discussion includes: How the FDA’s proposed rule on regulating LDTs has advanced to the White House Office of Managem...
Black History Month: Bill Morice, M.D., Ph.D.
February 29, 2024 07:00 - 8 minutes - 11.8 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to honor Black History Month. They reflect on important advancements in healthcare and laboratory medicine that were led by Black healthcare professionals and scholars. They also discuss health inequities that impact communities throughout the United States. Thei...
Adrenal Gland Tumors: Stefan Grebe, M.D., Ph.D., and Irina Bancos, M.D.
February 22, 2024 07:00 - 13 minutes - 18.3 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Stefan Grebe, M.D., Ph.D., co-director of the Clinical Mass Spectrometry and Test Development Laboratory in the Department of Laboratory Medicine and Pathology, and Irina Bancos, M.D.,consultant in the Division of Endocrinology, Diabetes, and Metabolism with a joint appointment in biochemistry and immunology. They discuss the diagnosis and ma...
Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D.
February 20, 2024 07:00 - 12 minutes - 17.3 MBAnn Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy for patients, who might be as young as age 2. (00:32) Could you please tell us a little bit about your background? (01:17) Could you please do a brief overview of our EOIBD test? (03:24) Which patients should have this testing and when s...
Emerging and Reemerging Diseases: Bill Morice, M.D., Ph.D.
February 15, 2024 07:00 - 11 minutes - 15.5 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss current activity of infectious diseases. Their discussion includes: Vector-borne diseases that are causing public health concerns, and the multi-agency public health strategy recently released by the U.S. Department of Health and Human Services to addr...
Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D.
February 13, 2024 07:00 - 16 minutes - 22.8 MBAnne Tebo, Ph.D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune liver disease. (00:32) Could you please provide a little information about your background? (02:09) Please give a brief overview of the new test panels. (05:35) Which patients should have this testing and when should it be performed? ...
Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.
February 06, 2024 07:00 - 17 minutes - 24.7 MBDavid Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the blood proteins, for improved patient care and simpler test ordering. (00:32) Could you provide us with a little bit about yourself and your background? (02:56) Would you elaborate on the role of you and the Mayo Clinic team in advancing insi...
The Pulse on Global Diagnostics: Bill Morice, M.D., Ph.D.
February 01, 2024 07:00 - 11 minutes - 15.4 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss what companies in the healthcare and diagnostics industries are focusing on in 2024. Their discussion includes: Insights from the J.P. Morgan Healthcare Conference, and where investments are happening in the diagnostics industry. Observations from vis...
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.
January 30, 2024 07:00 - 5 minutes - 7.16 MBJoshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique blood test identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal health. Speaker 3: (00:32) Can you share a little about yourself and your background? Speaker 3: (01:00) Can you provide us with an overview of this new preeclampsia assay? Speaker 3: (02:33) Can you share what will be reported with t...
Evolution of Syphilis: Elitza Theel, Ph.D.
January 18, 2024 07:00 - 13 minutes - 18 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to talk about the sexually-transmitted disease syphilis. Specific topics of discussion include: The history, cause, and symptoms of syphilis. A rare recent outbreak of ocular syphilis cases. The dramatic rise in syphilis and congenital syphilis c...
A New Year with Familiar Viruses: Bill Morice, M.D., Ph.D.
January 11, 2024 07:00 - 11 minutes - 16.1 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to welcome the new year and discuss the increase of respiratory viruses. Their discussion includes: The increasing number of COVID-19 and influenza cases across the United States. The endemic state of COVID-19 and tools for prevention. The continued need to pro...
Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.
January 04, 2024 07:00 - 8 minutes - 12 MBJeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk. Show notes (00:31) Could you provide us a little bit about your background? (01:20) Could you give us a brief overview of this assay? (02:45) What patients should have this test and when should it be performed? (04:2...
Test helps identify elusive central nervous system pathogens: Robin Patel, M.D.
January 02, 2024 07:00 - 7 minutes - 9.86 MBRobin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these infections. Show notes Speaker 3: (00:32) Please give us a brief introduction of yourself and your role at Mayo Clinic. Speaker 3: (01:44) Could you please expand a bit on this newly developed sequencing assay — which is a shotgun metagenomic tes...
Unique testing helps identify cause of sudden cardiac death: Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC
December 28, 2023 07:00 - 13 minutes - 18.4 MBLinnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC, describe how Mayo Clinic Laboratories' postmortem genetic tests can provide answers after a sudden unexplained cardiac death. Test results are important for managing family members' risk for cardiovascular disease. Show notes (00:32) Would each of you share a little bit about yourselves and your backgrounds? (01:13) Could you provide us with an overview of these new tests? (02:31) Can you expand on why these postmortem ...
Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.
December 26, 2023 07:00 - 10 minutes - 14.1 MBDevin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage. Show notes (00:32) Could you please provide us a little information about your background? (01:46) Could you please give the audience a brief overview of this assay? (03:45) Which patients should have this testing and when should it be performed? ...
The Past, Present, and Future of Diagnostics: Bill Morice, M.D., Ph.D.
December 21, 2023 07:00 - 13 minutes - 18.3 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to reflect on key moments from 2023 and to discuss what may lie ahead in 2024. Their discussion includes: A look back at impactful events from 2023 in laboratory medicine and diagnostics. What’s top of mind today heading into the holidays. Specula...
Assay identifies biomarker of autoimmune encephalitis subtype: Andrew McKeon, M.B., B.Ch., M.D.
December 19, 2023 07:00 - 17 minutes - 24.4 MBAntibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' GABA-A receptor antibody assay aids diagnosis of this serious but treatable condition. Show notes (00:32) Could you provide a little information on your role here at Mayo Clinic? (01:1...
Milestone Treatments for Sickle Cell Disease: Bill Morice, M.D., Ph.D.
December 14, 2023 07:00 - 15 minutes - 22 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the U.S. Food and Drug Administration’s (FDA) recent approval of two gene therapies for sickle cell disease. Their discussion includes: The cause and characteristics of sickle cell disease. How the new cell-based gene therapies, Casgevy ...
Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D.
December 12, 2023 07:00 - 16 minutes - 22.5 MBMaria Willrich, Ph.D., and Melissa Snyder, Ph.D., describe Mayo Clinic Laboratories' panel for proactive therapeutic drug monitoring of patients with inflammatory bowel disease. The panel expands options for clinicians assessing patients' response to the drugs infliximab and adalimumab. (00:32) Could you provide a little bit of background information about yourselves? (02:18) Would you give the audience a brief overview of the assay? (04:18) Which patients should have th...
Comments on the FDA’s Proposed Rule: Bill Morice, M.D., Ph.D.
December 07, 2023 07:00 - 13 minutes - 18.4 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the U.S. Food and Drug Administration’s (FDA) proposed rule on laboratory-developed tests (LDTs) and the comments Mayo Clinic submitted to the FDA. Their discussion includes: How Mayo Clinic responded in its comments to the FDA on the pro...
Protecting Against Winter Respiratory Viruses: Bill Morice, M.D., Ph.D.
November 30, 2023 07:00 - 11 minutes - 15.5 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss current respiratory virus activity and the importance of staying up-to-date on preventive vaccines. Their discussion includes: The current outlook on COVID-19 cases and the importance of remaining vigilant with prevention efforts. The r...
Congressional and Federal Updates: Bill Morice, M.D., Ph.D.
November 23, 2023 07:00 - 15 minutes - 21.7 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the one-year delay to clinical laboratory payment cuts recently passed by Congress and the importance of responding to the FDA’s proposed rule on laboratory-developed tests. Specific discussion points include: How Congress passed the sh...
Perspectives from Washington, D.C.: Bill Morice, M.D., Ph.D.
November 16, 2023 07:00 - 14 minutes - 19.6 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss key takeaways from Dr. Morice’s recent visit in Washington, D.C. Their discussion includes: How device manufacturers are evolving and collaborating within the changing landscape. The importance of submitting comments in response to th...
RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D.
November 14, 2023 07:00 - 10 minutes - 15 MBLisa Rimsza, M.D., explains how Mayo Clinic Laboratories' unique PM3CX test can accurately define subtypes of large B-cell lymphoma. Precise diagnosis is critical to choosing appropriate chemotherapy for these cancers. Speaker 2: (00:32) Could you provide a brief background about yourself? Speaker 2: (01:12) Would you give us an overview of the PM3CX test? Speaker 2: (03:02) Which patients should have this testing? Speaker 2: (05:14) Is this test qualitative and RN...
Safeguards for AI in Healthcare: Bill Morice, M.D., Ph.D.
November 09, 2023 07:00 - 10 minutes - 14.7 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss strategies for responsible innovation and how new standards for artificial intelligence (AI) safety will impact laboratory medicine and diagnostics. Their discussion includes: Highlights of the Executive Order issued by President Biden ...
A Possible Cure for Sickle Cell Disease: Bill Morice, M.D., Ph.D.
November 02, 2023 06:00 - 15 minutes - 21 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the recent news of a possible cure for sickle cell disease, as well as gene editing therapies and their impact on the laboratory. Their discussion includes: Characteristics of sickle cell disease and current testing and treatment optio...
Opportunities Around At-Home Testing: Bill Morice, M.D., Ph.D.
October 26, 2023 06:00 - 14 minutes - 20 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the role and expansion of at-home testing. Their discussion includes: How home test kits for COVID-19 led to the expansion of at-home tests and telehealth options across the health industry. Understanding from a laboratory perspective t...
How AI Can Add Value to Laboratory Medicine: Bill Morice, M.D., Ph.D.
October 19, 2023 06:00 - 13 minutes - 18.2 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss how artificial intelligence (AI) has become a disruptive technology in the field of laboratory medicine, and how it can add value to patient care. Their discussion includes: How the conversation around AI and laboratory medicine began, ...
Transformative Technologies: Bill Morice, M.D., Ph.D.
October 12, 2023 06:00 - 11 minutes - 16.2 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss current focus areas found across the diagnostics industry and what transformative technologies are being explored around the world. Their discussion includes: What international laboratories and diagnostics companies are working on duri...
Proposed Regulations for Laboratory Developed Tests: Bill Morice, M.D., Ph.D.
October 05, 2023 06:00 - 11 minutes - 16.2 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the U.S. Food and Drug Administration’s (FDA) recently proposed rule that if finalized, would phase out its current enforcement discretion used for laboratory developed tests (LDTs), and regulate all laboratory tests as medical devices re...
Seasonal Outlook of Respiratory Viruses: Matthew Binnicker, Ph.D.
September 28, 2023 06:00 - 15 minutes - 21.3 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo Clinic, to discuss the seasonal outlook of respiratory viruses, including influenza, COVID-19, and respiratory syncytial virus (RSV). Specific topics of discussion include: What respiratory viruses are currently circulating, and what we might expect...
Circulating Strains of COVID-19: Bill Morice, M.D., Ph.D.
September 21, 2023 06:00 - 11 minutes - 15.3 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the uptick of COVID-19 cases and the strains of the virus that are currently circulating. Their discussion includes: COVID-19 variants and how their mutations affect transmission. Lessons learned throughout the last few years with COVI...
What to Know About Leprosy: Nancy Wengenack, Ph.D.
September 14, 2023 06:00 - 13 minutes - 18.7 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories at Mayo Clinic, to talk about leprosy and why it’s been in the news recently. Leprosy, also known as Hansen’s disease, is a rare infectious disease caused by the bacteria Mycobacterium leprae. Specific topics of discussion include: How leprosy i...
Flea-borne Typhus: Elitza Theel, Ph.D.
August 31, 2023 06:00 - 11 minutes - 16.5 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic. They talk about murine typhus, also known as flea-borne typhus, and the recent increase in cases in Los Angeles County and Texas. Specific topics of discussion include: How flea-borne typhus is transmitted to humans and common symptoms...
Opioid Addiction and Substance Abuse Testing: Paul Jannetto, Ph.D.
August 24, 2023 06:00 - 22 minutes - 30.3 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Paul Jannetto, Ph.D., director of the Clinical and Forensic Toxicology Lab, Clinical Mass Spectrometry Lab, and Metals Lab at Mayo Clinic. Dr. Pritt and Dr. Jannetto discuss the current state of the opioid crisis in the United States, its impact on public health, and the important role of laboratory testing in addiction medicine...
Summertime Pathogens: Bill Morice, M.D., Ph.D.
August 17, 2023 06:00 - 10 minutes - 14.6 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss pathogens commonly found in the summertime that can cause disease and illness, and how to protect against them. Their discussion includes: Mosquito-borne and tick-borne diseases, their symptoms, and how to prevent bites. The U.S. Envir...